{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:28:08Z","timestamp":1793975288465,"version":"4.8.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["Sanction No.5\/4-5\/191\/ Neuro \/2019-NCD-I"],"award-info":[{"award-number":["Sanction No.5\/4-5\/191\/ Neuro \/2019-NCD-I"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bbrep.2026.102783","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:26:18Z","timestamp":1789010778000},"page":"102783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Alpha-synuclein and mitochondrial permeability transition pore interactions in rotenone-induced Parkinson\u2019s disease models: neuroprotective promise of cyclosporine A"],"prefix":"10.1016","volume":"48","author":[{"given":"Sukhpal","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aritri","family":"Bir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arindam","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit Kumar","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7737-0016","authenticated-orcid":false,"given":"Sankha Shubhra","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasanka","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2026.102783_bib1","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson's disease: etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbrep.2026.102783_bib2","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2147\/DDDT.S130514","article-title":"Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease","volume":"11","author":"Ganguly","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.bbrep.2026.102783_bib3","first-page":"281","article-title":"Postmortem studies in Parkinson's disease, Dialogues Clin","volume":"6","author":"Hartmann","year":"2004","journal-title":"Neurosci"},{"key":"10.1016\/j.bbrep.2026.102783_bib4","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009399","article-title":"\u03b1-Synuclein in Parkinson's disease","volume":"2","author":"Stefanis","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.bbrep.2026.102783_bib5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in Parkinson's disease","volume":"3","author":"Dias","year":"2013","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.bbrep.2026.102783_bib6","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/mds.23732","article-title":"Etiology and pathogenesis of Parkinson's disease","volume":"26","author":"Schapira","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbrep.2026.102783_bib7","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1742-4658.2012.08491.x","article-title":"Animal models of Parkinson's disease","volume":"279","author":"Blandini","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrep.2026.102783_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/jnc.13618","article-title":"Cellular models for Parkinson's disease","volume":"139","author":"Falkenburger","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrep.2026.102783_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/exnr.2002.8072","article-title":"Subcutaneous Rotenone exposure causes highly selective Dopaminergic degeneration and \u03b1-Synuclein aggregation","volume":"179","author":"Sherer","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbrep.2026.102783_bib10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A highly reproducible rotenone model of Parkinson's disease","volume":"34","author":"Cannon","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrep.2026.102783_bib11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.5114\/fn.2019.89857","article-title":"Rotenone: from modelling to implication in Parkinson's disease","volume":"57","author":"Radad","year":"2019","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.bbrep.2026.102783_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175129","article-title":"Protective effects of cyclosporine A on neurodegeneration and motor impairment in rotenone-induced experimental models of Parkinson's disease","volume":"929","author":"Singh","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrep.2026.102783_bib13","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbamcr.2010.09.013","article-title":"Is mPTP the gatekeeper for necrosis, apoptosis, or both?","volume":"1813","author":"Kinnally","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrep.2026.102783_bib14","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3390\/cells12091273","article-title":"The mitochondrial permeability transition pore\u2014current knowledge of its structure, function, and regulation, and optimized methods for evaluating its functional state","volume":"12","author":"Endlicher","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bbrep.2026.102783_bib15","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3389\/fnins.2019.01028","article-title":"The Impairments of \u03b1-Synuclein and mechanistic target of Rapamycin in Rotenone-induced SH-SY5Y cells and mice model of Parkinson's Disease","volume":"13","author":"Ramalingam","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbrep.2026.102783_bib16","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.bbadis.2011.02.013","article-title":"Mitochondrial dysfunction mediated by quinone oxidation products of dopamine: implications in dopamine cytotoxicity and pathogenesis of Parkinson's disease","volume":"1812","author":"Jana","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrep.2026.102783_bib17","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.febslet.2010.03.012","article-title":"\u03b1-Synuclein induced membrane depolarization and loss of phosphorylation capacity of isolated rat brain mitochondria: implications in Parkinson's disease","volume":"584","author":"Banerjee","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrep.2026.102783_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10522-010-9301-8","article-title":"Age-related oxidative decline of mitochondrial functions in rat brain is prevented by long term oral antioxidant supplementation","volume":"12","author":"Bagh","year":"2011","journal-title":"Biogerontology"},{"key":"10.1016\/j.bbrep.2026.102783_bib19","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1042\/BCJ20190676","article-title":"Interaction of \u03b1-synuclein and Parkin in iron toxicity on SH-SY5Y cells: implications in the pathogenesis of Parkinson's disease","volume":"477","author":"Ganguly","year":"2020","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrep.2026.102783_bib20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/10715762.2024.2336563","article-title":"Alpha-synuclein interaction with mitochondria is the final mechanism of ferroptotic deathinduced by erastin in SH-SY5Y cells","volume":"58","author":"Ganguly","year":"2024","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.bbrep.2026.102783_bib21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4103\/0976-500X.119726","article-title":"How to calculate sample size in animal studies?","volume":"4","author":"Charan","year":"2013","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.bbrep.2026.102783_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.molbrainres.2004.11.007","article-title":"Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures","volume":"134","author":"Testa","year":"2005","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.bbrep.2026.102783_bib23","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1016\/j.febslet.2010.10.046","article-title":"Secondary necrosis: the natural outcome of the complete apoptotic program","volume":"584","author":"Silva","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrep.2026.102783_bib24","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/jnc.12966","article-title":"\u03b1-synuclein-induced mitochondrial dysfunction in isolated preparation and intact cells: implications in the pathogenesis of Parkinson's disease","volume":"131","author":"Bir","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrep.2026.102783_bib25","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biocel.2011.01.014","article-title":"\u03b1-Synuclein overexpression impairs mitochondrial function by associating with adenylate translocator","volume":"43","author":"Zhu","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbrep.2026.102783_bib26","doi-asserted-by":"crossref","first-page":"18467","DOI":"10.1074\/jbc.M115.641746","article-title":"\u03b1-Synuclein shows high affinity interaction with voltage-dependent anion channel, suggesting mechanisms of mitochondrial regulation and toxicity in Parkinson disease","volume":"290","author":"Rostovtseva","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrep.2026.102783_bib27","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1038\/s41467-018-04422-2","article-title":"\u03b1-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease","volume":"9","author":"Ludtmann","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrep.2026.102783_bib28","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1152\/physrev.00026.2013","article-title":"Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release","volume":"94","author":"Zorov","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrep.2026.102783_bib29","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.redox.2017.07.005","article-title":"Redox regulation of proteasome function","volume":"13","author":"Lefaki","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbrep.2026.102783_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13024-017-0149-0","article-title":"The SH-SY5Y cell line in Parkinson's disease research: a systematic review","volume":"12","author":"Xicoy","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbrep.2026.102783_bib31","article-title":"Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology","volume":"1078","author":"Kovalevich","year":"2013"},{"key":"10.1016\/j.bbrep.2026.102783_bib32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neuro.2008.11.001","article-title":"Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research","volume":"30","author":"Cheung","year":"2009","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bbrep.2026.102783_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.brainres.2010.03.102","article-title":"Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies","volume":"1337","author":"Lopes","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.bbrep.2026.102783_bib34","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s13311-023-01414-z","article-title":"Cyclosporine as therapy for traumatic brain injury","volume":"20","author":"Hansson","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbrep.2026.102783_bib35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000446850","article-title":"A potential therapy of ischemic reperfusion injury. A common history for heart and brain","volume":"42","author":"Nighoghossian","year":"2016","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.bbrep.2026.102783_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105700","article-title":"Immune responses in the Parkinson's disease brain","volume":"168","author":"Weiss","year":"2022","journal-title":"Neurobiol. Dis."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826003432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826003432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:02:17Z","timestamp":1793973737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580826003432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":36,"alternative-id":["S2405580826003432"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102783","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alpha-synuclein and mitochondrial permeability transition pore interactions in rotenone-induced Parkinson\u2019s disease models: neuroprotective promise of cyclosporine A","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102783"}}